Lokavant Expands Team to Drive Strategic Direction of AI-Based Clinical Trial Feasibility Solution
Retrieved on:
Dienstag, Mai 7, 2024
Technology, Clinical Trials, Professional Services, Biotechnology, Health, Data Analytics, Other Science, Science, Artificial Intelligence, University, Sonata, Public health, Drug development, AI, Microsoft Excel, GSK plc, Advisory board, Doctor of Philosophy, Pharmacy, Artificial intelligence, Data science, ChromeOS, Data, Patient, RWD, Noise, Medicine, Bristol Myers Squibb, Public health genomics, Clinical trial, Genomics, Therapy, Roivant Sciences, Pharmaceutical industry
The Lokavant Advisory Board brings together accomplished leaders in pharmaceutical research and development who are experts in global clinical trial operations.
Key Points:
- The Lokavant Advisory Board brings together accomplished leaders in pharmaceutical research and development who are experts in global clinical trial operations.
- They work closely with the Lokavant leadership team, providing valuable insights into drivers for the evolving data and analytics needs of clinical trial sponsors and contract research organizations (CROs).
- “I’m excited to work with Aaron and the new advisory team to incorporate their learnings into our clinical trial intelligence platform and study feasibility applications.
- Together, we can drive efficiencies in trial operations while accelerating clinical research.”